ESC Premium Access

Poster session 2 - Digging deeper into oral anticoagulants

Event: ESC CONGRESS 2017
Topic: Miscellaneous
Session type: Poster Session
Date: 27 August 2017

Congress Session

5 presentations in this session

Clinical effectiveness of new oral anticoagulants in US and Europe for stroke prevention in atrial fibrillation

Speaker: Mr M. Tarsillo (North Haven, US)

Anti-Xa concentration better than activated partial thromboplastin time for the monitoring of unfractionated heparin treatment.

Speaker: Doctor T. Moumneh (Angers, FR)

Effects of factor Xa inhibitors rivaroxaban and apixaban on platelet function

Speaker: Associate Professor G. Renda (Chieti, IT)

Impact of hemorrhagic events during dual antiplatelet therapy after drug-eluting stent implantation in patients with hemodialysis

Speaker: Doctor A. Shimizu (Kitakyushu, JP)

Use of vitamin K antagonists in patients aged 85 years or over: analysis of thromboembolic and hemorrhagic events.

Speaker: Doctor D. Moreira (Sao Paulo, BR)

5 speakers from this session

Mr Marc Tarsillo

Quinnipiac University , North Haven (United States of America)
0 follower

Doctor Thomas Moumneh

University Hospital of Angers, Angers (France)
0 follower

Associate Professor Giulia Renda

G. d'Annunzio University, Institute of Cardiology and Center of Excellence on Aging, Chieti (Italy)
0 follower

Doctor Akiyoshi Shimizu

University of Occupational and Environmental Health, Kitakyushu (Japan)
0 follower

Doctor Dalmo Moreira

Dante Pazzanese Institute of Cardiology, Sao Paulo (Brazil)
0 follower

This platform is supported by

logo Novo Nordisk